Effects of Docosahexanoic Acid on Gut Microbiota and Fecal Metabolites in HIV-Infected Patients With Neurocognitive Impairment: A 6-Month Randomized, Double-Blind, Placebo-Controlled Trial

MLA

Ruihua Dong, et al. “Effects of Docosahexanoic Acid on Gut Microbiota and Fecal Metabolites in HIV-Infected Patients With Neurocognitive Impairment: A 6-Month Randomized, Double-Blind, Placebo-Controlled Trial.” Frontiers in Nutrition, vol. 8, Jan. 2022. EBSCOhost, https://doi.org/10.3389/fnut.2021.756720.

APA

Ruihua Dong, Haijiang Lin, Yingying Ding, Xiaoxiao Chen, Ruizi Shi, Shiying Yuan, Jing Li, Bowen Zhu, Xiaohui Xu, Weiwei Shen, Keran Wang, Ding Ding, & Na He. (2022). Effects of Docosahexanoic Acid on Gut Microbiota and Fecal Metabolites in HIV-Infected Patients With Neurocognitive Impairment: A 6-Month Randomized, Double-Blind, Placebo-Controlled Trial. Frontiers in Nutrition, 8. https://doi.org/10.3389/fnut.2021.756720

Chicago

Ruihua Dong, Haijiang Lin, Yingying Ding, Xiaoxiao Chen, Ruizi Shi, Shiying Yuan, Jing Li, et al. 2022. “Effects of Docosahexanoic Acid on Gut Microbiota and Fecal Metabolites in HIV-Infected Patients With Neurocognitive Impairment: A 6-Month Randomized, Double-Blind, Placebo-Controlled Trial.” Frontiers in Nutrition 8 (January). doi:10.3389/fnut.2021.756720.